Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
What’s likely to move the market in the next trading session
Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and…
Wegovy-maker Novo Nordisk to cut around 9,000 jobs
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…
Eli Lilly’s Daniel Skovronsky talks obesity pill data
The Eli Lilly headquarters in Indianapolis, Indiana, on Aug. 15, 2024. AJ Mast | Bloomberg | Getty Images…
Meta shares fall on AI restructuring report, while Lilly shrugs off Novo’s Ozempic price move
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Novo Nordisk offers diabetes drug Ozempic for steep cash discount
A box of Ozempic made by Novo Nordisk, at a pharmacy in London on March 8, 2024. Hollie…
10 things to watch in the stock market Monday including Nvidia and geopolitics
The Club’s 10 things to watch Monday, Aug. 18 — Today’s newsletter was written by Zev Fima, the…
Eli Lilly obesity pill orforglipron led to 12% weight loss
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…
Eli Lilly earnings are coming Thursday. What top analysts expect
Many on Wall Street expect that Novo Nordisk ‘s loss has been Eli Lilly ‘s gain, and this…
Novo Nordisk (NVO) earnings Q2 2025
Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024.…
Here are the 6 big things we’re watching in the market this week
Wall Street ended a busy week of earnings, economic data and policy decisions with a thud, as a…
U.S. tariff updates, jobs data
European stocks sharply lower European stock markets further extended losses in late deals, with the Stoxx 600 index…